Human Tumor Necrosis Factor-alpha Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Human Tumor Necrosis Factor-alpha antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHuman Tumor Necrosis Factor-alpha
Clone[NYRhTNFa-E2]
Host SpeciesMouse
Reactive Speciesn/a
IsotypeIgG1
Formation exchange purified
Size0.5 mg, 1 mg
Concentration1mg/ml in PBS (after reconstitution).
ApplicationsELISA (EIA), Western Blot (WB), Immunoprecipitation (IP), Intracellular Staining
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionIntroduction: Tumor necrosis factor is a cytokineinvolved in systemic inflammationand is a member of a group of cytokines that all stimulate the acute phase reaction. TNF is mainly secreted by macrophages. TNF causes apoptoticcell death, cellular proliferation, differentiation, inflammation, tumorigenesisand viral replication, TNF is also involved in lipid metabolism, and coagulation. TNF's primary role is in the regulation of immune cells.Dysregulation and, in particular, overproduction of TNF have been implicated in a variety of human diseases- autoimmune diseases, insulin resistance, and cancer.
ImmunogenImmunogen: r.Human TNF-a.
Other Names[TNF a; Tumor Necrosis Factor-alpha, Mouse-Human; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin; DIF; TNFA; TNFSF2], [TNF; TNF; DIF; TNFA; TNFSF2; TNF-alpha; TNFA; TNFSF2; TNF-a; NTF; ICD1; ICD2]
Gene, Accession #[TNF-a], Gene ID: 7124, NCBI: NP_000585.2
Catalog #MBS140025
Price$305, $455
Order / More InfoHuman Tumor Necrosis Factor-alpha Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.